These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1089613)

  • 1. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of infected urinary stones by urease inhibitor. IV. Treatment of infection stones in rats by a new hydroxamic acid and cefalexin].
    Takeuchi H; Tomoyoshi T; Okada Y; Yoshida O; Kobashi K
    Hinyokika Kiyo; 1983 Mar; 29(3):297-302. PubMed ID: 6375315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H; Kobashi K; Yoshida O
    Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of infected urinary stones by urease inhibition.
    Griffith DP; Musher DM
    Invest Urol; 1973 Nov; 11(3):228-33. PubMed ID: 4584162
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urease activity of bacteria in urine].
    Arai Y; Takeuchi H; Tomoyoshi T; Tatewaki K
    Hinyokika Kiyo; 1989 Feb; 35(2):277-81. PubMed ID: 2500012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid.
    Takeuchi H; Okada Y; Kobashi K; Yoshida O
    Urol Res; 1982; 10(4):217-9. PubMed ID: 6758273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
    Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O
    J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones.
    Millner OE; Andersen JA; Appler ME; Benjamin CE; Edwards JG; Humphrey DT; Shearer EM
    J Urol; 1982 Feb; 127(2):346-50. PubMed ID: 7038144
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acetohydroxamic acid on the induction of bacterial ureases.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    Invest Urol; 1980 Sep; 18(2):112-4. PubMed ID: 6997229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis.
    Satoh M; Munakata K; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1994 Aug; 40(8):689-94. PubMed ID: 7942366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus.
    Musher DM; Griffith DP; Yawn D; Rossen RD
    J Infect Dis; 1975 Feb; 131(2):177-81. PubMed ID: 234993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary calculi: microbiological and crystallographic studies.
    Rosenstein IJ
    Crit Rev Clin Lab Sci; 1986; 23(3):245-77. PubMed ID: 3524996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of urease as chemotherapeutic agents.
    Rosenstein IJ; Hamilton-Miller JM
    Crit Rev Microbiol; 1984; 11(1):1-12. PubMed ID: 6373150
    [No Abstract]   [Full Text] [Related]  

  • 17. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
    Griffith DP; Gibson JR; Clinton CW; Musher DM
    J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of urease by miscellaneous ions and compounds. Implications for the therapy of infection-induced urolithiasis.
    Burr RG
    Invest Urol; 1977 Sep; 15(2):180-2. PubMed ID: 903216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic chemotherapy with low-dosage trimethoprim-sulfamethoxazole following acute urinary tract infections in children.
    Sher N
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):16-8. PubMed ID: 1093647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureases as a target for the treatment of gastric and urinary infections.
    Follmer C
    J Clin Pathol; 2010 May; 63(5):424-30. PubMed ID: 20418234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.